MOUNTAIN VIEW, CA --(Marketwired - April 10, 2015) - VIVUS, Inc. (
14th Annual Needham Healthcare Conference April 14, 2015, 3:40pm EDT The Westin Grand Central Hotel, New York, NY
A live webcast and 30-day archive of the presentation will be available at http://ir.vivus.com .
About VIVUS
VIVUS is a biopharmaceutical company commercializing and developing innovative, next-generation therapies to address unmet needs in obesity, sleep apnea, diabetes and sexual health. For more information about the company, please visit www.vivus.com .
Certain statements in this press release are forward-looking within the meaning of the Private Securities Litigation Reform Act of 1995. These statements may be identified by the use of forward-looking words such as "anticipate," "believe," "forecast," "estimate," "expect," "intend," "likely," "may," "plan," "potential," "predict," "opportunity" and "should," among others. There are a number of factors that could cause actual events to differ materially from those indicated by such forward-looking statements. VIVUS does not undertake an obligation to update or revise any forward-looking statements. Investors should read the risk factors set forth in VIVUS's Form 10-K for the year ended December 31, 2014 as filed on February 25, 2015 and periodic reports filed with the Securities and Exchange Commission.
CONTACT : VIVUS, Inc. Dana B Shinbaum Corporate Development & Investor Relations shinbaum@vivus.com Investor Relations: The Trout Group Brian Korb bkorb@troutgroup.com 646-378-2923